CLINICAL_TRIALS
trial_result
· 2016-01-25
Clinical Trial Update: Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease [Phase 2]
Summary
A Phase 2 study evaluating rotigotine for late-onset Parkinson's disease in subjects aged 70 years and older has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Azienda Ospedaliera Cardinale G. Panico | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED